Bradley Willcox Joins Cardax Pharmaceuticals Inc. Scientific Advisory Board
6/27/2011 1:08:06 PM
More...
|
Cardax Pharmaceuticals Inc. Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
7/20/2009 9:07:33 AM
More...
|
Cardax Pharmaceuticals Inc. Appoints Gil Rishton, PhD, Chief Science Officer
5/26/2009 3:37:32 PM
More...
|
Cardax Pharmaceuticals Inc. Release: Study Finds Astaxanthin Is Potent Inhibitor Of Oxidation In Cell Membrane Model
1/2/2007 6:39:47 PM
More...
|
Cardax Pharmaceuticals Inc. Signs Joint Development And Supply Agreement With BASF
12/4/2006 1:52:01 PM
More...
|
Cardax Pharmaceuticals Inc. Appoints Fred Pashkow, MD, As EVP/CMO
10/9/2006 10:23:17 AM
More...
|